Add a listing
    Add a listing

    Cellvie

      pioneering Therapeutic Mitochondria Transfer, a novel treatment approach aimed at the cellular energy metabolism.

    General
    • Headquarters

      Houston, Texas, United States

    • Founders & Team

      Alexander Schueller, James McCully, Pedro del Nido, Sitaram Emani

    • Year Founded

      2018

    • Company type

      Private company

    • Funding stage

      Seed

    • Total funding ($M)

      5

    • Investors

      Kizoo Technology Capital

    Technical Details
    • Aging Target

      Mitochondrial dysfunction

    • Disease indication

      ischemia-reperfusion injury

    • Product modality

      mitochondrial transfusion, cell therapy

    About

    Founded in the US and headquartered close to Zürich, Switzerland, cellvie is developing medicines from cells, leveraging the therapeutic potential of mitochondria. The company was founded by Drs. McCully, Schueller, del Nido and Emani in 2018. Dr. McCully pioneered the approach of mitochondria augmentation and replacement at Harvard Medical School and the team has now set out to bring it about as a new treatment modality in ischemia-reperfusion injury, aging, and beyond. Further information can be found at cellvita-science.com

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In